Why Biotech and Pharma Companies Should Meet with NextPharma at CPHI Americas 2026?
As the pharmaceutical and biotech sectors continue to navigate increasingly complex development and manufacturing challenges, finding the right CDMO partner has never been more important. At NextPharma, we understand that companies are looking for more than capacity alone, they need flexibility, technical expertise, reliability, and a true development partner capable of supporting programs from early development through to commercial manufacture.
That is why the NextPharma team is looking forward to attending CPHI Americas 2026 from June 2-4, where we will be meeting with biotech and pharmaceutical companies to discuss how our integrated CDMO capabilities can help accelerate development timelines and reduce operational complexity and ensure reliable commercial supply.
NextPharma, a partner built around flexibility and expertise:
Biotech and emerging pharma companies often face critical development decisions under tight timelines and resource constraints. Choosing a CDMO with broad technical capabilities and a collaborative approach can significantly reduce risk during development and scale-up.
NextPharma offers integrated development and manufacturing services across multiple dosage forms and technologies, supporting customers through every stage of the product lifecycle. From formulation development and analytical services to clinical and commercial manufacturing, our teams work closely with customers to provide tailored solutions that align with program goals.
“Companies today need agile CDMO partners that can adapt quickly to changing program requirements while maintaining the highest quality standards,” said Josh Moule, Business Development Manager. “At NextPharma, we combine scientific expertise with operational flexibility to help our customers move programs forward efficiently and confidently.”
What to expect for 2026?
Industry events such as CPHI Americas provide a valuable opportunity for biotech and pharma companies to move beyond introductory conversations and engage directly with technical and commercial experts.
Meeting with NextPharma at the event allows attendees to:
- Discuss development or manufacturing challenges directly with experienced CDMO specialists
- Explore integrated solutions that simplify supply chains and technology transfer
- Identify opportunities to accelerate timelines and optimize development strategies
- Learn more about NextPharma’s specialized capabilities and manufacturing network
- Build relationships with teams focused on long-term partnership and collaboration
“Every program has unique technical and operational requirements,” said Josh Moule, Business Development Manager. “Meeting in person gives us the opportunity to better understand customer goals and identify the most effective path forward together.”
NextPharma supports a broad range of customers, from emerging biotech companies progressing their first clinical candidates to established pharmaceutical organizations seeking reliable commercial manufacturing support.
Our focus remains on delivering high-quality solutions backed by scientific expertise, regulatory excellence, and a customer-centric approach. Whether companies are seeking formulation support, clinical supply manufacturing, scale-up expertise, or commercial manufacturing capacity, NextPharma provides integrated services designed to support long-term success.
To arrange a meeting with our team during the event, please reach out directly to Josh: josh.moule@nextpharma.com.
We look forward to connecting with biotech and pharmaceutical companies and exploring how NextPharma can help bring the next generation of therapies to patients worldwide.